Risultati della ricerca - H. Kreipe

  • Mostra 1 - 4 risultati su 4
Raffina i risultati
  1. 1
    European Bone Marrow Working Group trial on reproducibility of World Health Organization criteria to discriminate essential thrombocythemia from prefibrotic primary myelofibrosis

    European Bone Marrow Working Group trial on reproducibility of World Health Organization criteria to discriminate essential thrombocythemia from prefibrotic primary myelofibrosis di T. Buhr, Konnie M. Hebeda, V. Kaloutsi, Anna Porwit, Jon van der Walt, H. Kreipe

    Pubblicazione 2011
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  2. 2
    De-escalation strategies in HER2-positive early breast cancer (EBC): final analysis of the WSG-ADAPT HER2+/HR− phase II trial: efficacy, safety, and predictive markers for 12 weeks of neoadjuvant dual blockade with trastuzumab and pertuzumab ± weekly paclitaxel

    De-escalation strategies in HER2-positive early breast cancer (EBC): final analysis of the WSG-ADAPT HER2+/HR− phase II trial: efficacy, safety, and predictive markers for 12 weeks... di Ulrike Nitz, Oleg Gluz, Matthias Christgen, E.‐M. Grischke, Doris Augustin, Sherko Küemmel, Michael Braun, Jochem Potenberg, A. Kohls, Katja Krauss, Andrea Stefek, Claudia Schumacher, Helmut Forstbauer, Toralf Reimer, Hans Holger Fischer, C Liedtke, Rachel Wuerstlein, Johannes Schumacher, Ronald Kates, H. Kreipe, Nadia Harbeck

    Pubblicazione 2017
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  3. 3
    Prognostic effect of calreticulin mutations in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantation

    Prognostic effect of calreticulin mutations in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantation di Victoria Panagiota, Felicitas Thol, Birgit Markus, Boris Fehse, Haefaa Alchalby, Anita Badbaran, Ulrich Lehmann, Christian Koenecke, Rabia Shahswar, Anuhar Chaturvedi, Michael Stadler, Matthias Eder, Gudrun Göhring, Michael Koenigsmann, Arnold Kloos, Arne Trummer, Thomas Schroeder, Guido Kobbe, Christian Thiede, Uwe Platzbecker, Brigitte Schlegelberger, H. Kreipe, Arnold Ganser, Nicolaus Kröger, Michael Heuser

    Pubblicazione 2014
    Testo Testo
    Carta
    Aggiungi alla lista
    Salvato in:
  4. 4
    TNBC-DX genomic test in early-stage triple-negative breast cancer treated with neoadjuvant taxane-based therapy

    TNBC-DX genomic test in early-stage triple-negative breast cancer treated with neoadjuvant taxane-based therapy di M. Martín, S.R. Stecklein, Oleg Gluz, Guillermo Villacampa, Marı́a del Monte-Millán, Ulrike Nitz, Sara López‐Tarruella, M. Christgen, F. Brasó-Maristany, Enrique Alarcón Álvarez, Isabel Echavarría, B. Conte, Sherko Küemmel, Coralia Bueno, Yolanda Jerez, R Kates, M. Cebollero, Cornelia Kolberg-Liedtke, Oscar Bueno, José Á. García-Sáenz, F. Moreno, Eva‐Maria Grischke, Helmut Forstbauer, Michael Braun, Mathias Warm, John Hackmann, Christoph Uleer, Bahriye Aktas, Christoph Schumacher, R Wuerstleins, MK Graeser, Christine zu Eulenburg, H. Kreipe, Henry Gómez, T. Massarrah, Blanca Herrero, Laia Paré, U. Bohn, S. López-Tarruella, A. Vivancos, Esther Sanfeliu, J.S. Parker, C.M. Perou, Patricia Villagrasa, A. Prat, Pradeep Kumar Sharma, N. Harbeck

    Pubblicazione 2024
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:

Strumenti per la ricerca: